Xu Haoyu of Yangtze River Pharmaceutical: quality should be kept in mind when Chinese medicine goes out

China China Pharmaceutical net China News May 9th China one belt, one road, Xu Haoyu, vice chairman of Yangzi Pharmaceutical Group, said in the "2018 China brand value evaluation information release and the second China brand development forum" "Quality revolution means" double promotion "of brand and quality "Root" is better than brand in quality Xu Haoyu said that Yangzijiang pharmaceutical has always put "high quality" in the position of core values of enterprises According to him, the longfengtang traditional Chinese medicine industrial park project under construction will strive to become an advanced fully automated, data-based and intelligent traditional Chinese medicine health industrial base in China "This is our revolution in the quality of traditional Chinese medicine, and also our exploration of the modernization of traditional Chinese medicine and the innovation of national medicine." Xu Haoyu said so
He pointed out that as a pharmaceutical manufacturer, to form a mechanism to continuously promote the quality revolution, we should not only combine the general policy of national reform, but also adhere to the quality concept of unswerving, firmly establish the concept of "quality" From the perspective of traditional Chinese medicine, we should strictly control the safety of the planting, processing and other links of traditional Chinese medicine, pay attention to the quality of genuine Chinese medicine, and ensure the quality of traditional Chinese medicine There is no problem of agricultural disability At the same time, we should keep abreast of international standards "The key for TCM to go global is to let overseas patients feel that TCM can cure diseases." He mentioned that "on the one hand, more experts should be sent to international standardization organizations, especially technical standardization organizations On the other hand, China's research institutions, enterprises, universities, etc should also make efforts to participate in or even influence the formulation of international standards in light of the actual situation " Therefore, Yangzijiang pharmaceutical industry takes the global performance management system as the standard, keeps pace with the international advanced quality management mode, and vigorously promotes the GMP certification of FDA and EU One belt, one road, China's enterprises "go out" has got a good opportunity for development According to Xu Haoyu, if Chinese brands want to "go global", they should establish the concept that "Chinese brands must have Chinese characteristics" To build a Chinese brand, we need to focus on quality, credit and service This process is inseparable from innovation He mentioned that as a large pharmaceutical group, strategic innovation is important "One belt, one road, is to integrate Chinese medicine culture and Chinese medicine culture, and raise the culture to a certain height Then we should use this culture to carry out the" one belt and one road " It is reported that the "2018 China brand value evaluation information release and the second China brand development forum" was guided by the State Administration of market supervision, hosted by the economic daily, China Council for the promotion of international trade and China brand building Promotion Association, and hosted by China brand magazine and China economic network.